NewEdge Advisors, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1633516
NEW ORLEANS, LA
Position in REGN
as of Mar 31, 2026
· filed Jun 3, 2026
Position Value
$5,879,790
-$1,777,160 QoQ
Shares Held
7,610
-23.3% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 3.6005256241787125.ToString("F0")%
Shared 0.ToString("F0")%
None 96.3994743758213.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NewEdge Advisors, LLC holds $33,544,404 across 116 Biotechnology names. REGN ranks #2 (17.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
17,146 | $7,656,374 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
7,610 | $5,879,790 | |
| 3 | NUVB |
Nuvation Bio Inc.
|
1,031,112 | $4,423,470 | |
| 4 | PHAT |
Phathom Pharmaceuticals, Inc.
|
183,000 | $2,033,130 | |
| 5 | INCY |
Incyte Corp
|
20,416 | $1,921,553 | |
| 6 | EXEL |
Exelixis, Inc.
|
33,985 | $1,457,616 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
24,351 | $1,375,587 | |
| 8 | INSM |
INSMED Inc
|
6,015 | $983,572 |
All Filings in REGN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,879,790 | 7,610 | Shares | Sole | 2026-06-03 | |
| 2025-12-31 | $7,656,950 | 9,920 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $2,267,072 | 4,032 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $1,017,450 | 1,938 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,293,829 | 2,040 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,994,524 | 2,800 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $4,656,993 | 4,430 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,590,899 | 4,368 | Shares | Sole | 2024-08-16 | |
| 2024-03-31 | $3,953,908 | 4,108 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $4,149,920 | 4,725 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $2,095,256 | 2,546 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,567,343 | 3,573 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,092,738 | 4,981 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,899,668 | 4,019 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,516,202 | 2,201 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $733,592 | 1,241 | Shares | Sole | 2022-08-09 | |
| 2021-12-31 | $958,647 | 1,518 | Shares | Sole | 2022-02-17 | |
| 2021-09-30 | $393,972 | 651 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $347,411 | 622 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $290,507 | 614 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $347,839 | 720 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $415,356 | 742 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $389,157 | 624 | Shares | Sole | 2020-07-29 | |
| 2020-03-31 | $533,700 | 1,093 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||